These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30448615)

  • 21. Electrophysiological correlates of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism.
    Roy N; Barry RJ; Fernandez FE; Lim CK; Al-Dabbas MA; Karamacoska D; Broyd SJ; Solowij N; Chiu CL; Steiner GZ
    Sci Rep; 2020 Oct; 10(1):17915. PubMed ID: 33087740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The BDNF val66met polymorphism is associated with decreased use of landmarks and decreased fMRI activity in the hippocampus during virtual navigation.
    West GL; Konishi K; MacDonald K; Ni A; Joober R; Bohbot VD
    Eur J Neurosci; 2021 Oct; 54(7):6406-6421. PubMed ID: 34467592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults.
    Ward DD; Summers MJ; Saunders NL; Janssen P; Stuart KE; Vickers JC
    Behav Brain Res; 2014 Sep; 271():309-15. PubMed ID: 24946073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project.
    Thow ME; Summers MJ; Summers JJ; Saunders NL; Vickers JC
    Neurobiol Aging; 2017 Jul; 55():175-176. PubMed ID: 28438485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.
    Kim A; Fagan AM; Goate AM; Benzinger TL; Morris JC; Head D;
    Cogn Affect Behav Neurosci; 2015 Sep; 15(3):625-43. PubMed ID: 25784293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BDNF Val66Met polymorphism moderates the relationship between cognitive reserve and executive function.
    Ward DD; Summers MJ; Saunders NL; Ritchie K; Summers JJ; Vickers JC
    Transl Psychiatry; 2015 Jun; 5(6):e590. PubMed ID: 26125153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].
    Zhang C; Gu X; Wang Q; Li M; Deng W; Guo W; Zhao L; Ma X; Li T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):592-596. PubMed ID: 28777866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands.
    Benzerouk F; Gierski F; Gorwood P; Ramoz N; Stefaniak N; Hübsch B; Kaladjian A; Limosin F
    Alcohol; 2013 Jun; 47(4):271-4. PubMed ID: 23582695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran.
    Rezaei S; Asgari Mobarake K; Saberi A; Keshavarz P; Leili EK
    Neurol Sci; 2016 Jun; 37(6):935-42. PubMed ID: 27071687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the Brain-Derived Neurotrophic Factor Val66Met Polymorphism Modulate the Effects of Physical Activity and Exercise on Cognition?
    de Las Heras B; Rodrigues L; Cristini J; Weiss M; Prats-Puig A; Roig M
    Neuroscientist; 2022 Feb; 28(1):69-86. PubMed ID: 33300425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex and BDNF Val66Met polymorphism matter for exercise-induced increase in neurogenesis and cognition in middle-aged mice.
    Islas-Preciado D; Splinter TFL; Ibrahim M; Black N; Wong S; Lieblich SE; Liu-Ambrose T; Barha CK; Galea LAM
    Horm Behav; 2023 Feb; 148():105297. PubMed ID: 36623432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review.
    Toh YL; Ng T; Tan M; Tan A; Chan A
    Brain Behav; 2018 Jul; 8(7):e01009. PubMed ID: 29858545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDNF Val66Met polymorphism and protein levels in amniotic fluid.
    Cattaneo A; Bocchio-Chiavetto L; Zanardini R; Marchina E; Bellotti D; Milanesi E; Moraschi S; Calabrese F; Barlati S; Riva MA; Gennarelli M
    BMC Neurosci; 2010 Feb; 11():16. PubMed ID: 20141627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition.
    Beste C; Baune BT; Domschke K; Falkenstein M; Konrad C
    Neuroscience; 2010 Mar; 166(1):178-84. PubMed ID: 20034542
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Boots EA; Schultz SA; Clark LR; Racine AM; Darst BF; Koscik RL; Carlsson CM; Gallagher CL; Hogan KJ; Bendlin BB; Asthana S; Sager MA; Hermann BP; Christian BT; Dubal DB; Engelman CD; Johnson SC; Okonkwo OC
    Neurology; 2017 May; 88(22):2098-2106. PubMed ID: 28468845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
    Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction effect between BDNF val66met polymorphism and obesity on executive functions and frontal structure.
    Marqués-Iturria I; Garolera M; Pueyo R; Segura B; Hernan I; García-García I; Sánchez-Garre C; Vernet-Vernet M; Sender-Palacios MJ; Narberhaus A; Ariza M; Junqué C; Jurado MÁ
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):245-53. PubMed ID: 24619555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.